Additional European Equity News

Adidas (ADS GY), JD Sports (JD/ LN), Puma (PUM GY) - Lululemon -22.4% after hours post-earnings. (Newswires) 

AstraZeneca (AZN LN) - Calquence (acalabrutinib) has been approved in the EU. (Newswires) 

Galderma (GALD SW) - Long-term data on Nemluvio (nemolizumab) demonstrate its favourable safety profile and sustained and increased improvements in itch and skin lesions in patients with atopic dermatitis up to two years (Galderma)

H&M (HMB SS) - H&M's founding family has quietly increased share purchases, spending over SEK 63bln since 2016, raising speculation of a move to take the fast-fashion retailer private, Bloomberg reported. The company has been publicly listed in Stockholm since 1974, though family members deny plans for privatisation. (Bloomberg)

NN Group (NN NA) upgraded to buy from hold at Deutsche Bank

UK Housing - UK Halifax House Prices MM* (May) -0.4% vs. Exp. -0.1% (Prev. 0.3%); Halifax said “Affordability remains a challenge, with house prices still high relative to incomes. However, lower mortgage rates and steady wage growth have helped support buyer confidence...The outlook will depend on the pace of cuts to interest rates, as well as the strength of future income growth and broader inflation trends. Despite ongoing pressure on household finances and a still-uncertain economic backdrop, the housing market has shown resilience – a story we expect to continue in the months ahead.” (Halifax)

Valneva (VLA FP) - Positive Chikungunya vaccine data noted for children Phase III in FY26. (Newswires) 

Broker Moves

Allianz (ALV GY) downgraded to hold from buy at Deutsche Bank

PostNL (PNL NA) cut to reduce from hold at Kepler 

06 Jun 2025 - 07:45- EquitiesEU Research- Source: Newswires